Skip to main content

Advertisement

Log in

Molecular pathology of inflammatory cardiomyopathy

  • Original Investigation
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

Endomyocardial biopsy (EMB) is often performed in patients presenting with sudden onset of heart failure to identify myocarditis. The introduction of immunohistochemical techniques for the detection and differentiation of infiltrating immune cells, specific adhesion molecules and MHC class I and II molecules increased the prognostic value of EMB in the diagnosis of myocarditis considerably. A major breakthrough in the understanding of pathogenetic mechanisms in myocarditis was achieved by diagnostic use of molecular biological methods. By application of in situ hybridization and PCR, enteroviruses, and more recently, parvovirus B19 (PVB19) have been identified as relevant agents of myocarditis. The different cell tropism of these viruses implicates distinct pathogenic principles, which, at present, are not completely understood. Whereas enteroviruses damage the heart primarily via direct lysis of infected myocytes, PVB19 does not infect myocytes, but endothelial cells of small intracardiac arterioles and venules, resulting in impairment of myocardial microcirculation with secondary myocyte necrosis during acute infection. Histological and immunohistological stainings combined with molecular biological approaches in EMB will help us to resolve the question of whether patients with myocarditis should be treated by specific antiviral agents or by immunosuppressive therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1. A
Fig. 2. A
Fig. 3. A

Similar content being viewed by others

References

  1. Aretz HT (1987) The Dallas criteria. Hum Pathol 18:619–624

    CAS  PubMed  Google Scholar 

  2. Baboonian C, Treasure T (1997) Meta-analysis of the association of enteroviruses with human heart disease. Heart 78:539–543

    CAS  PubMed  Google Scholar 

  3. Bültmann B, Klingel K, Sotlar K, Bock, CT, Baba H, Kandolf R (2003) Fatal PVB19 myocarditis clinically mimicking ischemic heart disease: an endothelial cell mediated disease. Hum Pathol 34:92–95 (in press)

    Google Scholar 

  4. Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis—natural history and treatment. Multicenter giant cell myocarditis study group investigators. N Engl J Med 336:1860–1866

    Article  PubMed  Google Scholar 

  5. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312:885–890

    PubMed  Google Scholar 

  6. De Leeuw N, Melchers WJ, Balk AH, Jonge N de, Galama JM (1999) Study on microbial persistence in end-stage idiopathic dilated cardiomyopathy. Clin Infect Dis 29:522–525

    PubMed  Google Scholar 

  7. Dingli D, Pfizenmaier DH, Arromdee E, Wennberg P, Spittell PC, Chang-Miller A, Clarke BL (2000) Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 356:312–314

    CAS  Google Scholar 

  8. Enders G, Dotsch J, Bauer J, Nutzenadel W, Hengel H, Haffner D, Schalasta G, Searle K, Brown KE (1998) Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis 26:355–358

    CAS  PubMed  Google Scholar 

  9. Finkel TH, Torok TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, Harbeck RJ, Gelfand EW, Saulsbury FT, Hollister JR, Anderson LJ (1994) Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343:1255–1258

    CAS  PubMed  Google Scholar 

  10. Frustaci A, Pieroni M, Chimenti C (2002) The role of endomyocardial biopsy in the diagnosis of cardiomyopathies. Ital Heart J 3:348–353

    PubMed  Google Scholar 

  11. Fukae S, Ashizawa N, Morikawa S, Yano K. (2000) A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med 39:632–366

    CAS  PubMed  Google Scholar 

  12. Griffin LD, Kearney D, Ni J, Jaffe R, Fricker FJ, Webber S, Demmler G, Gelb BD, Towbin JA (1995) Analysis of formalin-fixed and frozen myocardial autopsy samples for viral genome in childhood myocarditis and dilated cardiomyopathy with endocardial fibroelastosis using polymerase chain reaction (PCR). Cardiovasc Pathol 4:3–11

    CAS  Google Scholar 

  13. Grist NR, Reid D (1988) General pathogenicity and epidemiology. In: Bendinelli M, Friedman H (eds) Coxsackieviruses- a general update. Plenum Press, New York, pp 221–239

  14. Grumbach IM, Heim A, Pring-Akerblom P, Vonhof S, Hein WJ, Müller G, Figulla HR (1999) Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy. Acta Cardiol 54:83–88

    CAS  PubMed  Google Scholar 

  15. Hebert MM, Yu C, Towbin JA, Rogers BB (1995) Fatal Epstein-Barr virus myocarditis in a child with repetitive myocarditis. Pediatr Pathol Lab Med 15:805–812

    CAS  PubMed  Google Scholar 

  16. Herskowitz A, Ahmed-Ansari A, Neumann DA, Beschorner WE, Rose NR, Soule LM, Burek CL, Sell KW, Baughman KL (1990) Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol 15:624–632

    CAS  PubMed  Google Scholar 

  17. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL (1994) Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 24:1025–1032

    CAS  PubMed  Google Scholar 

  18. Kandolf R, Klingel K, Zell R, Selinka HC, Schneider-Brachert W, Bültmann B (1993) Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 35:140–151

    CAS  PubMed  Google Scholar 

  19. Kawai C (1999) From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: Lerning from the past for the future. Circulation 99:1091–1100

    CAS  PubMed  Google Scholar 

  20. Klingel K (2002) Molecular biologic detection of virus infection in myocarditis and dilated cardiomyopathy. In: Cooper LT Jr (ed) Myocarditis: From bench to bedside. Humana Press, Totowa, pp 295–324

  21. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage and inflammation. Proc Natl Acad Sci USA 89:314–318

    CAS  PubMed  Google Scholar 

  22. Li Y, Bourlet T, Andreoletti L, Mosnier JF, Peng T, Yang Y, Archard LC, Pozzetto B, Zhang H (2000) Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation 101:231–234

    CAS  PubMed  Google Scholar 

  23. Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearney D, Zhang YH, Bodurtha J, Gelb B, Ni J (1994) Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90:330–339

    CAS  PubMed  Google Scholar 

  24. Martino TA, Liu P, Sole MJ (1994) Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74:182–188

    CAS  PubMed  Google Scholar 

  25. Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S (2000) Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 80:1137–1142

    CAS  PubMed  Google Scholar 

  26. Murphy JG, Frantz RP (2002) Endomyocardial biopsy in myocarditis. In: Cooper LT Jr (ed) Myocarditis: From bench to bedside. Humana Press, Totowa, pp 371–389

  27. Ni J, Bowles NE, Kim YH, Demmler G, Kearney D, Bricker JT, Towbin JA (1997) Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation 95:133–139

    CAS  PubMed  Google Scholar 

  28. Nigro G, Bastianon V, Colloridi V, Ventriglia F, Gallo P, D'Amati G, Koch WC, Adler SP (2000) Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 31:65–69

    CAS  PubMed  Google Scholar 

  29. Okabe M, Fukuda K, Arakawa K, Kikuchi M (1997) Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 96:22–24

    CAS  PubMed  Google Scholar 

  30. Pankuweit S, Hufnagel G, Eckhardt H, Herrmann H, Uttecht S, Maisch B (1998) Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin 93:223–228

    CAS  PubMed  Google Scholar 

  31. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kühl U, Schwimmbeck PL, Schultheiss HP, Towbin JA (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic leftventricular dysfunction. Circulation 99:1348–1354

    CAS  PubMed  Google Scholar 

  32. Ray CG, Icenogle TB, Minnich LL, Copeland JG, Grogan TM (1989) The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis. J Infect Dis 159:829–836

    CAS  PubMed  Google Scholar 

  33. Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P. (2000) Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 81:2755–2762

    CAS  PubMed  Google Scholar 

  34. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93:841–842

    PubMed  Google Scholar 

  35. Rohayem J, Dinger J, Fischer R, Klingel K, Kandolf R, Rethwilm A (2001) Fatal myocarditis associated with acute parvovirus 19 and human herpesvirus 6 coinfection. J Clin Microbiol 39:4585–4587

    Article  CAS  PubMed  Google Scholar 

  36. Schmaltz AA, Demel KP, Kallenberg R, Neudorf U, Kandolf R, Klingel K, Bültmann B (1998) Immunosuppressive therapy of chronic myocarditis in children: three cases and the design of a randomized prospective trial of therapy. Pediatr Cardiol 19:235–239

    Article  CAS  PubMed  Google Scholar 

  37. Schönian U, Crombach M, Maser S, Maisch B (1995) Cytomegalovirus-associated heart muscle disease. Eur Heart J 16 Suppl O:46–49

    Google Scholar 

  38. Schowengerdt KO, Ni J, Denfield SW, Gajarski RJ, Bowles NE, Rosenthal G, Kearney DL, Price JK, Rogers BB, Schauer GM, Chinnock RE, Towbin JA (1997) Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 96:3 549–54

    PubMed  Google Scholar 

  39. Strauer BE, Kandolf R, Mall G, Maisch B, Mertens T, Figulla HR, Schwartzkopff B, Brehm M, Schultheiss HP (2001) Update 2001. Myocarditis—cardiomyopathy. Med Klin 96:608–625

    CAS  PubMed  Google Scholar 

  40. Tam PE, Messner RP (1999) Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 73:10113–10121

    CAS  PubMed  Google Scholar 

  41. Thanopoulos BD, Rokas S, Frimas CA, Mantagos SP, Beratis NG (1989) Cardiac involvement in postnatal rubella. Acta Paediatr Scand 78:141–144

    CAS  PubMed  Google Scholar 

  42. Veinot JP (2002) Diagnostic endomyocardial biopsy pathology: general biopsy considerations, and its use for myocarditis and cardiomyopathy: a review. Can J Cardiol 18:55–65

    PubMed  Google Scholar 

  43. Virmani R, Burke AP, Farb A, Smialek J (1995) Problems in forensic cardiovascular pathology. In: Schoen FJ, Gimbrone MA Jr (eds) Cardiovascular pathology: Clinicopathologic correlations and pathogenetic mechanisms. Williams & Wilkins, Baltimore, pp 173–196

  44. Wessely R, Klingel K, Santana L F, Dalton N, Hongo M, Lederer WJ, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453

    CAS  PubMed  Google Scholar 

  45. Wu TC, Pizzorno MC, Hayward GS, Willoughby S, Neumann DA, Rose NR, Ansari AA, Beschorner WE, Baughman KL, Herskowitz A (1992) In situ detection of human cytomegalovirus immediate-early gene transcripts within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS 6:7777–7785

    Google Scholar 

  46. Young NS (1996) Parvoviruses. In: Fields BN, Knipe DM, Howley PM (eds) Virology. Lippincott-Raven, Philadelphia, pp 2199–2220

Download references

Acknowledgements

This work was supported in parts by the Federal Ministry of Education, Science, Research and Technology and the Interdisciplinary Center for Clinical Research of the Medical Faculty of the University of Tübingen (IZKF 01 KS 9602), the Deutsche Forschungsgemeinschaft (Schn 628/1), and the fortüne programme of the University of Tübingen (no. 951-0-0).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karin Klingel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klingel, K., Sauter, M., Bock, C.T. et al. Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol 193, 101–107 (2004). https://doi.org/10.1007/s00430-003-0190-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-003-0190-1

Keywords

Navigation